Raid Captures 82 Million Doses of Counterfeit Drugs in Africa - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Raid Captures 82 Million Doses of Counterfeit Drugs in Africa


ePT--the Electronic Newsletter of Pharmaceutical Technology

An operation spanning 16 African countries and conducted by the World Customs Organization (WCO) in partnership with the Institute of Research against Counterfeit Medicines (IRACM) led to the seizure of more than 82 million doses of counterfeit medicines. The drugs seized included antimalarials, antibiotics, cough medicines, contraceptive pills, and fertility treatments, and were valued at around $40 million.

The operation was conducted simultaneously at 16 major seaports on the east and west coasts of Africa between July 11, 2012, and July 20, 2012. Customs officials seized more than 100 million counterfeit products of all categories. Of a total of 110 shipping containers inspected, 84 contained counterfeit or illegal products, with the largest shipments found in Angola, Togo, Cameroon, and Ghana. The majority of the shipments originated from South Asia, East Asia, and the Middle East.

According to a joint press release from IRACM and WCO, customs officers involved were trained by WCO, with the support of IRACM and experts from the pharmaceutical sector, to recognize the technical characteristics of various products that are subject to counterfeiting and to implement new detection methods. According to the release, the organizations expect to extend the operation to other continents in the coming months.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here